A liquid biopsy signature predicts treatment response to fluoropyrimidine plus platinum therapy in patients with metastatic or unresectable gastric cancer: implications for precision oncology

Detalles Bibliográficos
Autores principales: Lee, In-Seob, Zhu, Zhongxu, Lee, Jeeyun, Park, Joon Oh, Wu, Xiwei, Ong, Tiffany, Li, Sierra Min, Wang, Xin, Chao, Joseph, Goel, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722275/
https://www.ncbi.nlm.nih.gov/pubmed/34980153
http://dx.doi.org/10.1186/s12943-021-01483-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722275/
https://www.ncbi.nlm.nih.gov/pubmed/34980153
http://dx.doi.org/10.1186/s12943-021-01483-8

Ejemplares similares